1981
DOI: 10.1007/978-1-4684-8643-8_85
|View full text |Cite
|
Sign up to set email alerts
|

Basic Phenomena Underlying Novel use of Cholinergic Agents, Anticholinesterases and Precursors in Neurological Including Peripheral and Psychiatric Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1986
1986
1998
1998

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…In the 1950s, potent cholinesterase inhibitors such as diisofluoropropylphosphate (''dyflos'') were also tested in schizophrenics and reported to trigger psychotic episodes (Rowntree, Nevis, & Wilson, 1950). To the extent that the effects of systemically administered drugs assist in the discussion of the hypothesis that cortical cholinergic hyperactivity mediates the development of schizophrenic symptoms, the psychotic effects of chronic administration of cholinesterase inhibitors in humans provide support for this hypothesis (for further references see Karczmar, 1981).…”
Section: Cortical Cholinergic Hyperactivity In Schizophrenia: Evidencmentioning
confidence: 99%
“…In the 1950s, potent cholinesterase inhibitors such as diisofluoropropylphosphate (''dyflos'') were also tested in schizophrenics and reported to trigger psychotic episodes (Rowntree, Nevis, & Wilson, 1950). To the extent that the effects of systemically administered drugs assist in the discussion of the hypothesis that cortical cholinergic hyperactivity mediates the development of schizophrenic symptoms, the psychotic effects of chronic administration of cholinesterase inhibitors in humans provide support for this hypothesis (for further references see Karczmar, 1981).…”
Section: Cortical Cholinergic Hyperactivity In Schizophrenia: Evidencmentioning
confidence: 99%
“…Subsequently, Himwich, Bovet, Oliverio, JOllvet, Deutsch, Drachman, Stein, Russel, and others demon strated the effects of atropinics, anti-ChEs, and choliner gic agonists and antagonists (whether given directly into localized CNS sites or given systemically in the case of drugs capable of crossing the blood-brain barrier) on learning and memory, arousal and sleep, nociception, aggression, fear, addiction, and reward-punishment be havior (Waser 1975;Karczmar 1967Karczmar , 1970Karczmar , 1981Karczmar , 1990Hintgen and Aprison 1976). The cholinergic correlates of these functions and behaviors were established not only by the nature of the drugs employed but also by the presence of the cholinergic pathways in the perti nent brain areas and the demonstration of the release of ACh following either the stimulation of these path ways or the evocation of these functions (Pepeu 1993).…”
Section: Central Cholinergic Pathwaysmentioning
confidence: 99%